BPC 157 Dosing (Common Protocols), Oral Subcutaneous, 500 mcg daily, Duration: 6 weeks, Intramuscular Peritendinous, 1 mg daily, Duration: 6 weeks, Note:, Not approved by FDA or Peptide Therapy EPMWC BPC157 Dosing Recommendations by Weight TikTok Stable Gastric Pentadecapeptide BPC 157 as Therapy After Surgical Detachment of the Quadriceps Muscle from Its Attachments for Muscle to Bone Reattachment in Rats Frontiers Pharmacokinetics, distribution, metabolism, and excretion of body protective compound 157, a potential drug for treating various wounds, in rats and dogs Peptides for Plastic Surgery Recovery: A Clinical Guide to GLOW, KLOW, and NAD Plus Frank Agullo, MD